.svg){kind=small}
May-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
In May 2026, DermaFreeze operated as a single-category brand with Topical accounting for 100.0% of sales share, while Topical sales fell 94.76% year over year and 85.83% month over month; average price in Topical rose 1.52% YoY to $19.77. With rank data unavailable in Arizona Topical, the combination of a 100.0% category concentration and an 85.83% MoM contraction indicates the mix is fully exposed to short-cycle volatility; the thesis is that DermaFreeze’s mono-category dependence in May 2026 magnified downside from abrupt demand compression.
The 100.0% reliance on Topical alongside a 94.76% YoY decline and a 1.52% YoY price uptick implies price rigidity amid volume attrition, positioning DermaFreeze as a niche offering rather than a diversified player. The absence of a state-category rank in Arizona combined with the 85.83% MoM drop suggests distribution or shelf presence erosion, meaning the current positioning centers on narrow, possibly seasonal use cases where small pricing moves do not offset steep traffic loss; the thesis is that May 2026 marked a pivot point where sustaining relevance likely requires either cross-category expansion or re-entry tactics within Topical to rebuild baseline velocity.
Competitive Landscape
DermaFreeze sits at #11 in AZ Topical in May 2026, falling 6 spots YoY from #5 to #11 and dropping 4 positions since February 2026 when it was #7; this contrasts with Drip Oils + Extracts advancing from #2 to #1 and Gramz jumping from #7 to #3 with 123.2% YoY sales growth, while Chronic Health edged up from #3 to #2 despite a 28.0% YoY sales decline. Compared to its peak at #5 in June 2025, DermaFreeze’s slide to #11 over 11 months and a 4-rank drop in the last three months indicate that gains are consolidating at the top among faster risers and that DermaFreeze’s current trajectory implies share is migrating toward leaders unless the brand reverses the multi-period rank erosion.
Notable Products
DermaFreeze CBD/THC 5:1 Advanced Topical Nano-Gel (500mg CBD, 100mg THC, 4oz) led May 2026 with rank 1 but plunged by 85.8% month over month, despite holding the top position, indicating volume retrenchment around a single flagship. With only one Topical SKU represented in the top 10 and sales at $1,326, the contrast between rank 1 and an 85.8% decline implies fragile leadership concentrated in one product rather than a broad-based lineup. The pattern suggests DermaFreeze is overexposed to a single Topical SKU and needs portfolio depth to stabilize month-over-month volatility.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
